Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.
Journal: Annals of clinical and translational neurology
Published: August 01, 2024
Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
Journal: CNS neuroscience & therapeutics
Published: November 16, 2021
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: March 31, 2014
Showing 1-5 of 5
Last Updated: 09/26/2026